Most Recent

The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.

1 Comment

image: Image of the Day: Older and Wiser

Image of the Day: Older and Wiser

By Sukanya Charuchandra | June 8, 2018

As the years go by, seabirds such as gannets get better at foraging.  

0 Comments

image: Dogs in Southern China Host Several Strains of Flu

Dogs in Southern China Host Several Strains of Flu

By Sukanya Charuchandra | June 6, 2018

They may be a prospective source for an influenza pandemic, researchers warn.  

0 Comments

The results suggest the virus could severely alter brain development in infants infected after birth, but blocking a signaling protein early on might ease certain symptoms.

0 Comments

Researchers find that conserving marsupials on a predator-free island dampens their avoidance behaviors, which could mean trouble for their reintroduction to mainland Australia.

0 Comments

image: Image of the Day: Black-Eyed Rage

Image of the Day: Black-Eyed Rage

By Sukanya Charuchandra | June 6, 2018

When defensive, guppies display a warning sign to their counterparts. 

0 Comments

Compared with their urban counterparts, babies and toddlers in rural Nigeria have gut microbiota that more closely resembles that of adults in their community.

0 Comments

image: New Insights to Improve CAR T Cells’ Safety

New Insights to Improve CAR T Cells’ Safety

By Vicki Brower | June 5, 2018

Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.

0 Comments

image: A T-Cell Tweak Combats Advanced Breast Cancer

A T-Cell Tweak Combats Advanced Breast Cancer

By Ashley Yeager | June 5, 2018

The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.

0 Comments

image: Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

By Sukanya Charuchandra | June 4, 2018

Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

0 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46